Przykład: Heart Attack

Badania kliniczne na Niedobór kofaktora molibdenu

Łącznie 6 wyników

NCT02629393

Rekrutacyjny

Study of ORGN001 (Formerly ALXN1101) in Neonates, Infants and Children With Molybdenum Cofactor Deficiency (MOCD) Type A

Warunki: Molybdenum Cofactor Deficiency, Type A
NCT01640717

Zakończony

A Retrospective, Observational, Noninterventional Data Collection Study for Patients With Molybdenum Cofactor Deficiency Who Have Been Previously Treated With Cyclic Pyranopterin Monophosphate (cPMP)

Warunki: Molybdenum Cofactor Deficiency
NCT00957749

Wycofane

Study of cPMP (Precusor Z) to Treat Molybdenum Cofactor Deficiency (MoCD) Type A

Warunki: Molybdenum Cofactor Deficiency Type A
NCT02047461

Aktywny, nie rekrutujący

Safety & Efficacy Study of ORGN001 (Formerly ALXN1101) in Pediatric Patients With MoCD Type A Currently Treated With rcPMP

Warunki: Molybdenum Cofactor Deficiency, Type A
NCT01735188

Zakończony

A Natural History Study of Molybdenum Cofactor and Isolated Sulfite Oxidase Deficiencies

Warunki: Molybdenum Cofactor Deficiency; Isolated Sulfite Oxidase Deficiency
NCT01894165

Zakończony

Phase 1 Single Dose Study of ALXN1101 in Healthy Volunteers

Warunki: Molybdenum Cofactor Deficiency (MoCD); Rare Autosomal Recessive Disorder; Deficiency of Activity of Molybdenum-dependent Enzymes (Sulfite Oxidase [SOX], Xanthine Dehydrogenase, and Aldehyde Oxidase)